Tissue Engineering Market Research Report Up to 2031

Visiongain has published a new report on Tissue Engineering Market Report 2021-2031: Forecasts by Application (Cord Blood & Cell Banking, Cancer, GI & Gynaecology, Dental, Orthopaedics, Musculoskeletal, & Spine). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/tissue-engineering-market-2021/#download_sampe_div

The capability of tissue engineering techniques in treating irreparable damage of tissues has boosted the market growth. Moreover, a rise in demand for reformative medicine and tissue engineering procedures to treat damaged tissues further increases this growth.

COVID-19 Impact on Tissue Engineering Market
Tissue engineering market will spur during the spread of pandemic COViD-19, as the market finds multiple application areas which includes Cord Blood & Cell Banking, Cancer, GI & Gynaecology, Dental, Orthopaedics, Musculoskeletal, & Spine which are ever-increasing areas of spread of disease.

Market Drivers

Driver 1
Tissue engineering provides substitutes to surgical reconstruction, transplants, and other automated devices that are used to repair injured tissues. The market for tissue engineering is also boosted by a constant increase in the need for effective regenerative treatments owing to a rise in the prevalence of diabetes, obesity, and other disorders due to lifestyle changes, aging population, and growing trauma cases.

Segment Analysis
Orthopaedics, musculoskeletal, and spine segment led the market for tissue engineering in 2019 due to the rise in the occurrence of musculoskeletal disorders. The orthopaedic regenerative segment includes the spine, bone substitutes, and bone grafts. According to the U.S. Medicare and Medicaid facility, there are around 900,000 surgeries every year that need bone replacement or reconstruction. The healthcare expenditure in the U.S. is increased by USD 60 billion owing to the prevalence of approximately 15 million fracture cases yearly.

Get Detailed TOC @ https://www.visiongain.com/report/tissue-engineering-market-2021/#download_sampe_div

Competitive Landscape
Some of the companies profiled in the market for tissue engineering include Medtronic plc; Zimmer Biomet Holdings, Inc; Allergan plc; Athersys, Inc; ACell, Inc.; Organogenesis Holdings Inc; Tissue Regenix Group plc; Stryker Corporation; RTI Surgical, Inc.; Integra Life Sciences Corporation; ReproCell, Inc.; and Baxter International, Inc.

Recent Developments
• Key players are entering into contracts and partnerships to gain a competitive advantage over their competitors. For instance, in March 2019, ACell and MyungMoon Bio Co. Ltd., signed an exclusive distribution contract for the circulation of ACell’s Cytal Wound Matrix and MicroMatrix wound management solutions in South Korea. MyungMoon is a reputed distributor and manufacturer of drugs and medical devices in South Korea.
• Additionally, major players are in a process of development of new tissue engineering products and up-gradation of their product ranges to cater the current demand. For instance, in April 2019, ACell received an additional 510(k) FDA clearance for its Gentrix product line. This headed to an increase in indications for use of the company’s Gentrix surgical matrix products.
• Besides this, companies such as Histogenics Corp.; MiMedix Group, Inc.; Genzyme; and DiscGenics have work in progress products with constructive results in preclinical and clinical trials. Anticipated successful launch of these products during the forecast period is expected to make a significant contribution towards market growth.

Request Customized Report as Per Your Requirements @ https://www.visiongain.com/contact/

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Tissue Engineering market and leading companies. You will find data, trends and predictions.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Research Insight : https://www.visiongain.com/tissue-engineering-market-analysis/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

This release was published on openPR.